Breast Flashcards
(76 cards)
What are the subtypes of breast cancer?
invasive ductal carcinoma (most common)
invasive lobular carcinoma
ductal carcinoma in situ
lobular carcinoma in situ
Paget’s disease
breast cancer genetics
BRCA1/2 - increased risk
(any woman under 50 with breast cancer will be tested regardless of their family history)
urgent referral criteria
- unexplained lump or skin changes in over 30
- nipple changes in over 50
non-urgent referral criteria
unexplained lump in under 30s
investigations
clinical examination - breast and axillary nodes
radiological ( US (under 40), mammogram (over 40)
biopsy (needle core biopsy)
Inflammatory breast cancer
rare but aggressive
causes lymph vessels of the skin to become blocked
Triple negative breast cancer
lacks oestrogen receptors and progesterone receptors and does not express HER2 protein on cancer cells
HER2 positive breast cancer
HER2 protein is expressed which promotes the growth of cancer cells
Breast screening programme
women aged 50-70 invited every 3 years for mammogram (women over 70 can still self refer)
surgical management for breast cancer
Wide local excision or mastectomy, including axillary node clearance if sentinel node biopsy shows infiltration (reconstruction at same time or later)
radiotherapy in breast cancer
- recommended following WLE to reduce recurrence
- may be given to patients with higher stage cancer following mastectomy
when is chemotherapy given in breast cancer?
- hormone receptor negative
- HER2 positive
chemo may be given to downstage tumours prior to surgery
common chemos used in breast cancer
- an anthracycline (doxorubicin)
- a taxane (paclitaxel)
biological therapy for HER2 positive patients with T1c+ (in combo with surgery, chemo and radiotherapy)
trastuzumab (Herceptin)
what should be monitored for patients taking trastuzumab (Herceptin)?
cardiac function
biological therapy for HER2 negative, hormone receptor positive breast cancer?
Abermaciclib (selectively inhibits cyclin-dependent kinases 4 and 6)
biological therapy for triple negative breast cancer
pembrolizumab
biological therapy for BRCA positive, HER2 negative high-risk early breast cancer.
Olaparib
when can hormonal therapies be used in breast cancer treatment?
for oestrogen receptor positive breast cancer
hormonal therapy for post-menopausal women with ER +ve
anastrozole (aromatase inhibitor)
hormonal therapy for pre-menopausal women with ER +ve breast cancer
tamoxifen (oestrogen receptor antagonist)
biphosphonates in the treatment of breast cancer
- may be used for reducing occurrence in node-positive cancers
- advised for treatment-induced menopause in women treated with aromatase inhibitors
zoledronic acid in breast cancer treatment
shows to improve disease-free survival in postmenopausal women with node-positive invasive cancer
complications of breast cancers
- fatigue
- bone and brain metastases
- psychological difficulties
- recurrence (locally, regionally or distant i.e liver, lungs, brain and bone)